| Name | OT antagonist 1 |
|---|
| Description | OT antagonist 1 (Compound 4) is a potent, selective Oxytocin antagonist with a Ki of 50 nM. |
|---|---|
| Related Catalog | |
| Target |
Ki: 50 nM (Oxytocin)[1] |
| In Vitro | Oxytocin (OT) is a nonapeptide hormone that acts on the OT receptor, a seven-transmembrane (7TM) (Gq-coupled) receptor. The OT receptor has no subtypes but is related to the vasopressin receptors V1A, V1B and V2. OT antagonists have therapeutic potential in a number of areas including pre-term labour: Benign Prostatic Hyperplasia and sexual dysfunction. As a result there is significant interest in the identification of potent, selective, orally bioavailable OT antagonists[1]. |
| References |
| Molecular Formula | C22H22N4O3 |
|---|---|
| Molecular Weight | 390.44 |